Management of fibromyalgia syndrome in 2016.
Fibromyalgia syndrome is a chronic pain disorder and defies definitively efficacious therapy. In this review, we summarize the results from the early treatment research as well as recent research evaluating the pharmacological, interventional and nonpharmacological therapies. We further discuss future directions of fibromyalgia syndrome management; we specifically focus on the issues that are associated with currently available treatments, such as the need for personalized approach, new technologically oriented and interventional treatments, the importance of understanding and harnessing placebo effects and enhancement of patient engagement in therapy.
Department of Anaesthesiology, Pain Management & Research Center, University of Utah, 615 Arapeen Drive, Suite 200, Salt Lake City, UT 84108, USA.
Akiko
A
Okifuji
Department of Anaesthesiology, Pain Management & Research Center, University of Utah, 615 Arapeen Drive, Suite 200, Salt Lake City, UT 84108, USA.
Jeff
J
Gao
Department of Anaesthesiology, Pain Management & Research Center, University of Utah, 615 Arapeen Drive, Suite 200, Salt Lake City, UT 84108, USA.
Christina
C
Bokat
Department of Anaesthesiology, Pain Management & Research Center, University of Utah, 615 Arapeen Drive, Suite 200, Salt Lake City, UT 84108, USA.
Bradford D
BD
Hare
D059350:Chronic Pain / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D005260:Female; D005356:Fibromyalgia / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008297:Male; D059408:Pain Management / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
exercise; fibromyalgia; interventional treatment; multidisciplinary therapy; pharmacological treatment; placebo; treatment engagement